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Abstract Surface-enhance resonance Raman scattering
spectra of the heme–thiolate enzyme cytochrome P450 2D6
(CYP2D6) adsorbed on Ag electrodes coated with 11-mer-
captoundecanoic acid (MUA) were obtained in various
experimental conditions. An analysis of these spectra, and a
comparisonbetweenthemandtheRRspectraofCYP2D6in
solution, indicated that the enzyme’s active site retained its
nature of six-coordinated low-spin heme upon immobiliza-
tion.Moreover,thespectralchangesdetectedinthepresence
of dextromethorphan (a CYP2D6 substrate) and imidazole
(an exogenous heme axial ligand) indicated that the immo-
bilized enzyme also preserved its ability to reversibly
bind a substrate and form a heme–imidazole complex. The
reversibility of these processes could be easily veriﬁed by
ﬂowing alternately solutions of the various compounds and
the buffer through ahome-builtspectroelectrochemicalﬂow
cell which contained a sample of immobilized protein,
without the need to disassemble the cell between consecu-
tive spectral data acquisitions. Despite immobilized
CYP2D6 being effectively reduced by a sodium dithionite
solution,electrochemicalreductionviatheAgelectrodewas
not able to completely reduce the enzyme, and led to its
extensiveinactivation.Thisbehaviorindicatedthatalthough
the enzyme’s ability to exchange electrons is not altered by
immobilization per se, MUA-coated electrodes are not sui-
ted to perform direct electrochemistry of CYP2D6.
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Abbreviations
5cHS Five-coordinated high spin
6cLS Six-coordinated low spin
CYP Cytochrome P450
DX Dextromethorphan
MUA 11-Mercaptoundecanoic acid
MV Methyl viologen
NTA Nitrilotriacetic acid
RR Resonance Raman
SAM Self-assembled monolayer
SERRS Surface-enhanced resonance Raman scattering
Introduction
Heme proteins are a large class of proteins having a
substituted iron porphyrin as a cofactor, with functions
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catalysis. Heme enzymes such as cytochromes P450 (CYPs)
and other oxygenases, being able to bind several substrates
and to use electrons from their heme iron to drive a catalytic
reaction, seem to be promising for nanobiotechnological
applications in biosensing and biocatalysis [1, 2].
The immobilization of enzymes on solid supports or
electrodes is a commonly used approach for constructing
biosensors or biocatalytic devices [3, 4]. In principle,
electrodes can be used as a source of electrons to drive a
catalytic reaction, or as elements of biosensors which
translate a molecular event such as substrate binding into a
measurable electric signal.
The question arises whether immobilization preserves
the protein function or rather induces losses of enzymatic
activity, and what structural changes cause the dysfunction
[1]. Therefore, techniques capable of probing the activity
and the structure of enzymes immobilized on surfaces are
valuable.
Surface-enhanced resonance Raman scattering (SERRS)
has proven to be a sensitive and selective spectroscopic
technique to study heme proteins immobilized on metal
surfaces, and it has been used to characterize the active site
of proteins such as cytochromes c, cytochrome c oxidase
and CYPs [5]. This technique is based on the inelastic
scattering of laser radiation whose wavelength is in reso-
nance with an electronic transition of the molecule studied
[6–8], leading to a signal enhancement denoted as the res-
onance Raman (RR) effect. In the case of proteins having a
heme as a chromophore, the porphyrin vibrational modes
are intensiﬁed over the other protein vibrations if the laser
wavelength falls within an associated electronic absorption
band. The heme moiety can thus be selectively investigated
without a dominating interference due to the protein matrix.
Additional sensitivity is gained through surface enhance-
ment (or surface-enhanced Raman scattering effect) if the
protein is close to a metal surface with particular charac-
teristics. Depending on the molecule studied and on the
experimental conditions applied, the synergy between the
two signal-enhancing effects (i.e., SERRS) sometimes
reaches single-molecule sensitivity [9–12], therefore
allowing the study of enzymes immobilized on surfaces,
typically consisting of very low amounts of sample (i.e.,
from a few layers to submonolayers of protein).
To fulﬁll the requirements to achieve both resonance
enhancementandsurfaceenhancement,silveristhesurface-
enhancingmetal ofchoice [7].Recently,heme proteinssuch
as cytochromes c [5, 13–19] and CYP101 [20] have been
investigated using SERRS on roughened Ag electrodes
coated with self-assembled monolayers (SAMs) of several
different alkanethiols and their derivatives. SAMs of func-
tionalizedalkanethiolsareamongthemostversatilecoatings
for both electrostatic and covalent immobilization of pro-
teins to metal surfaces, having the additional advantage of
preventing possible negative consequences of the direct
contact between the protein and the metal [5, 21]. Besides
technological applications, SERRS on SAM-coated elec-
trodes can become an important tool in fundamental studies
about protein–membrane and protein–protein interactions.
In fact, because of their structure and characteristics, SAMs
canbethoughtofasaroughmodelforbiologicalmembranes
[5, 13], or can be used to mimic the binding domain of a
partner protein, since surface properties such as polarity and
charge can be selected by choosing the appropriate alka-
nethiol derivative [13, 22]. Moreover, electrochemically
roughened Ag electrodes coated with SAMs were recently
shown to be excellent for studying immobilized proteins
with voltammetric techniques, so both SERRS and voltam-
metry can be performed on the same sample [19].
In the work reported here, we exploited SERRS to study
the behavior of the human enzyme CYP2D6 electrostati-
cally immobilized on a Ag electrode coated with a SAM of
11-mercaptoundecanoic acid (MUA). CYPs are heme–
thiolate monooxygenases capable of oxidizing and reducing
a broad range of endogenous and exogenous substrates and
can be found in all kinds of tissues in virtually all organisms
[23]. CYP2D6 is a peripheral membrane-bound protein and
is one of the most important CYPs in humans, being
involved in the metabolism of about 30% of the currently
marketed drugs, including b-blockers, neuroleptics, anti-
depressants and antiarythmics [24, 25]. Its characteristics
make this enzyme not only attractive for technological
applications as a biocatalyst or biosensor, but also from a
toxicological and clinical point of view. In fact, a better
understanding of its mechanisms of catalysis could help in
developing more efﬁcient drugs [26, 27].
Using a home-built SERRS spectroelectrochemical ﬂow
cell [28], we investigated the CYP2D6 active-site structure
under diverse experimental conditions in order to check the
functionality of the immobilized enzyme, its redox activity
and its ability to bind reversibly a substrate or an exogenous
heme ligand such as imidazole. Besides conﬁrming the
retention of the enzyme’s function upon immobilization,
SERRSspectrayieldinformationaboutstructuralchangesin
the active site associated with substrate binding and electron
transfer, the initial two steps of a CYP catalytic cycle.
Materials and methods
Chemicals
The pSP19T7LT plasmid containing bicistronically human
CYP2D6 with a C-terminal His6-tag and human NADPH-
CYP reductase,was kindly provided by Magnus Ingelman-
Sundberg. Dextromethorphan (DX), imidazole, MUA and
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123sodium dithionite were purchased from Sigma-Aldrich (St
Louis, USA). Emulgen 911 was obtained from KAO
Chemicals (Tokyo, Japan). Nickel nitrilotriacetic acid
(NTA) agarose was from Sigma. Phosphate buffer solu-
tions (pH 7.4, 40 mM) were prepared from K2HPO4 and
KH2PO4 (J.T. Baker, Deventer, The Netherlands). All other
chemicals were of analytical grade and were obtained from
standard suppliers.
Expression and puriﬁcation of CYP2D6
The pSP19T7LT plasmids containing wild-type CYP2D6
were transformed in Escherichia coli, strain JM109.
Expression, membrane isolation and puriﬁcation were
carried out as previously described [29]. In short, mem-
branes were resuspended in 0.5% of the original culture
volume of potassium phosphate–glycerol buffer (50 mM
potassium phosphate buffer, pH 7.4, 10% glycerol) and
CYP contents were determined by CO difference spectra
[30]. The enzyme was solubilized by stirring in potassium
phosphate–glycerol supplemented with 0.5% Emulgen 911
for 2 h at 4  C. Insoluble parts were removed by centri-
fugation (60 min, 120,000g at 4  C). The supernatant was
mixed, while gently rocking it, with nickel nitrilotriacetic
acid agarose for 60 min at 4  C. The nickel nitrilotriacetic
acid agarose was then applied to a polypropylene tube with
a porous disk (Pierce, Perbio Science, Etten-Leur, The
Netherlands), washed with potassium phosphate–glycerol
buffer containing 2 mM histidine. Subsequently, bound
CYP2D6 was eluted with 0.2 M histidine. After overnight
dialysis in potassium phosphate–glycerol buffer the sample
was concentrated on a Vivaspin 20 ﬁltration tube (10,000
MWCO PES, Sartorius, Nieuwegein, The Netherlands) to a
ﬁnal concentration of 60 lM CYP2D6.
Spectroelectrochemical ﬂow cell
SERRS measurements were performed using a modiﬁed
version of a linearly moving low-volume spectroelectro-
chemical cell previously described [28]. The cell was
originally designed to acquire potential-dependent SERRS
spectra from proteins adsorbed on roughened Ag electrodes
using a Raman microscope in a backscattering conﬁgura-
tion. The modiﬁed version of this cell used in the present
work has the possibility to ﬂow a solution through the cell
via two small holes (0.75-mm diameter each; Fig. 1). By
using a valve, a liquid-chromatography pump (Gilson,
Middleton, USA) and ﬂexible PEEK tubing (VICI Interna-
tional, Schenkon, Switzerland), the thin layer (0.3 mm) of
solution in contact with the Ag electrode surface can be
changed by ﬂowing different solutions though the
spectroelectrochemicalcell,withouttheneedtodisassemble
the cell itself (Fig. 1). Moreover, by degassing the solutions
with argon and by using oxygen-proof PEEK tubing, the
presence of oxygen, which can interfere with electrochem-
ical and spectroscopic measurements, can be minimized in
thecell.Itshouldbenotedthatsmallinternaldiameterofthe
liquid-chromatography tubing (0.75 mm) and the low
internalvolumeofthecell(approximately50 lL)allowsthe
use of relatively small amounts of solutions.
Raman spectroscopy instrumentation
Spectroscopic measurements were conducted by placing the
spectroelectrochemical cell under a home-built Raman
microscope in a backscattering conﬁguration: a Zeiss
microscope (D-7082 with a ·40 objective, numerical
aperture 0.60, working distance 2 mm) was coupled to an
Andor Shamrock SR-303i-A single monochromator (Andor
Technologies DV-420OE, Belfast, UK) with a mounted
2,400 g mm
–1 holographic grating and an Andor Newton
DU970N CCD camera. The 413.1 nm line of a continuous-
wave Kr ion laser (Innova 300C, Coherent, Santa Clara,
CA, USA) was used for excitation. The Rayleigh scattered
light was removed using third millennium edge long pass
ﬁlter. Laser powers of 5 mW at the sample and an accu-
mulation time of 180 s were used throughout the
experiments. To avoid sample photodegradation, the cell
was put in a moving holder which ensured a constant linear
movement of the metal electrode surface under the micro-
scope objective, while keeping the focus approximately
constant [28]. The monochromator slit was set to 120 lm,
yielding a resolution of approximately 4 cm
–1, with an
increment of approximately 0.8 cm
–1 per data point.
The sloping background of the spectra was subtracted
using a baseline ﬁtted to the experimental data with the
Andor CCD camera software, while the ﬁtting of the
CYP2D6 spectrum at –1.0 V with Lorentzian functions
was performed with PeakFit
1 version 4.12 (SeaSolve
Software, Richmond, CA, USA).
Electrochemical instrumentation
Polycrystalline silver disk electrodes (IJ Cambria Scien-
tiﬁc, Burry Port, UK) of 2-mm diameter (geometric
area 0.0314 cm
2) were used as working electrodes; a
platinum ring and a saturated calomel electrode (AMEL
Instruments, Milan, Italy), were used as the counter elec-
trode and the reference electrode, respectively. The
reference electrode was kept in a glass tube ﬁlled with a
40 mM potassium phosphate buffer solution and separated
from the working solution by a PEEK porous frit. It was
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123kept at constant room temperature (20 ± 0.1  C) during all
the experiments. The three-electrode system was controlled
with a lAutolab potentiostat (Eco Chemie, Utrecht, The
Netherlands). All potentials are referred to a saturated
calomel electrode, previously calibrated against the methyl
viologen (MV) MV
2+/MV
+ couple.
Sample preparation
SERRS measurements were performed on electrochemi-
cally roughened Ag electrodes coated with MUA, prepared
as follows. Ag electrodes were treated as previously
described [31] with water on aluminum oxide lapping ﬁlm
sheets (261· and 262·,3 M
TM) from 5- to 1-lm grain size
until a mirrorlike appearance of the surfaces was obtained.
After they had been polished, the electrodes were rough-
ened ex situ with an oxidation–reduction cycle procedure
similar to that described by Roth et al. [32] and then kept
overnight in 2 mM ethanol solution of MUA. The oxida-
tion–reduction cycles (approximately 0.67 C cm
–2 of
anodic charge passed per step) were performed in an
ordinary glass electrochemical cell (5 mL) ﬁlled with a
0.1 M KCl solution using the three-electrode system
described already.
The MUA-coated Ag electrodes were rinsed with etha-
nol to eliminate the excess of MUA, dried by gently
blowing nitrogen on them and then immersed into 50 lLo f
a3lM solution of protein in potassium phosphate buffer
(40 mM, pH 7.4, 10% glycerol) for at least 3 h at 4  C, to
induce adsorption of the protein on the electrode. Then, the
coated electrodes with the adsorbed protein were rinsed
with buffer to eliminate possible excess of loosely bound
protein, and were put into the spectroelectrochemical cell
described already.
Depending on the required experimental conditions,
before every SERRS measurement the appropriate solution
was ﬂowed for 1–2 min into the cell: for measurements in
the absence of DX or imidazole, a potassium phosphate
buffer (40 mM, pH 7.4) was used, while for measurements
in the presence of DX or imidazole, solutions of DX
(5 mM, 0.02% of methanol) or imidazole (10 mM) in
buffer were used. The solutions of DX were prepared by
diluting with buffer a 2 M stock solution of DX in meth-
anol. To chemically reduce the protein in the absence or
presence of substrate, sodium dithionite solutions (5 mg
mL
–1) were prepared using buffer solutions or DX solu-
tions (5 mM) in buffer, and were ﬂowed for 1–2 min into
the cell before every SERRS measurement. Prior to use, all
the solutions ﬂowed into the cell were deoxygenated for at
least 3 h with argon.
RR measurements were performed using buffered
CYP2D6 solutions in spinning glass capillaries as previ-
ously described [33]. To chemically reduce the enzyme in
out in
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Fig. 1 The surface-enhanced resonance Raman scattering (SERRS)
spectroelectrochemical ﬂow system. The degassed solutions are
pumped though PEEK liquid-chromatography tubing into the cell
and then to the waste. A switching valve is used to select which
solution has to be pumped. A scheme of the cell is shown in detail,
with the inlet and outlet for the ﬂowing solution and the three
electrodes: the Ag working electrode (WE), the Pt counter electrode
(CE) and the connection though a porous frit to a saturated calomel
electrode (SCE) reference electrode (RE). The laser for Raman
excitation is focused by the microscope objective onto the Ag
electrode through a glass cover and a layer of solution
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(to a ﬁnal concentration of 5 mg mL
–1) was added to a
buffered 3–5 lM protein solution in presence of 5 mM DX,
previously degassed with argon.
Results and discussion
The resting state
Intense SERRS spectra (Fig. 2, spectra a) were observed
from CYP2D6 immobilized via electrostatic interaction
[34] on MUA-coated Ag electrodes at open circuit (i.e.. no
external potential is applied), in the presence of phosphate
buffer. These experimental conditions should reproduce the
‘‘resting state’’ of the enzyme (i.e.. the starting point of its
catalytic cycle) when no substrate is present in the active
site and no reaction is taking place [35, 36]. A MUA-SAM
was chosen as the coating because of its structural stability,
its compatibility with CYP2D6 [34] and its use in recent
SERRS studies on bacterial CYP101 [20] and on cyto-
chrome c [5, 13].
The most intense band of the SERRS spectra is
observed at 1,371 cm
–1, and a group of bands are detected
between 1,450 and 1,650 cm
–1. The frequencies of the
vibrational modes above 1,300 cm
–1 are correlated with
the oxidation, the spin and the coordination state of the
iron atom and therefore they are referred to as ‘‘marker
bands’’ for such properties [37]. The most relevant marker
bands in CYP2D6 SERRS spectra are assigned to the
corresponding vibrational modes on the basis of former
RR studies of CYP2D6 [33] and other CYPs [37]i n
buffered solution (Table 1). According to the frequencies
observed, the heme iron in the enzyme active site is oxi-
dized (Fe
3+), mainly six-coordinated low-spin (6cLS)
state, as is usually expected from a CYP in its resting state
[36, 37]. An extensive amount of experimental data from
other CYPs as well as theoretical studies showed that in
the 6cLS state the Fe
3+ atom has the four pyrrolic nitro-
gens of the porphyrin macrocycle as equatorial ligands,
and a cysteine and a water molecule (or hydroxyl ion) as
axial ligands [35, 36].
The observation of an oxidized 6cLS state is in agree-
ment with spectroscopic data on CYP2D6 previously
reported. In particular, the SERRS spectrum of CYP2D6
under these conditions is identical to the RR spectrum of
the same enzyme in buffer [33, 38] (Fig. 3 spectra b
and b0). An analogous correspondence with RR data was
recently reported for SERRS spectra of CYP2D6 adsorbed
on Ag nanoparticles coated with MUA [34]. This striking
Fig. 2 A SERRS spectra of cytochrome P450 (CYP) 2D6 on an 11-
mercaptoundecanoic acid (MUA)-coated Ag electrode obtained by
consecutively ﬂowing different solutions in the spectroelectrochem-
ical cell (at open circuit), in the following order: a buffer, b
dextromethorphan (DX) buffered solution, c buffer (rinse), d imid-
azole-buffered solution, e buffer (second rinse), f dithionite and DX
solution in phosphate buffer. The 1,300–1,450-cm
–1 regions of
spectra b–e are identical to that of spectrum a and are omitted for
visual clarity. B Detailed view of the 1,450–1,660-cm
–1 region of the
CYP2D6 SERRS spectra in presence of a buffer, b DX and d
imidazole. Bands corresponding to the m2 and m3 vibrational modes for
the six-coordinated low-spin and ﬁve-coordinated high-spin heme
species are indicated. Experimental details are given in ‘‘Materials
and methods’’
J Biol Inorg Chem (2008) 13:85–96 89
123similarity in the position and relative intensity of SERRS
and RR spectra suggests that, differently from what was
recently reported for CYP101 [20], CYP2D6 retains its
active-site structure upon adsorption on the SAM-coated
electrode, or at least that there are no structural changes
inducing signiﬁcant alterations in heme properties.
Reversible binding of a substrate
Although the active-site structure is likely to be unaffected
by the protein–surface interaction, the functioning of the
adsorbed enzyme still has to be veriﬁed. According to the
accepted scheme of the catalytic cycle common to most
CYPs, the heme iron may experience changes in its coor-
dinationsphereanditsspinasaconsequenceofthepresence
ofsubstratesintheactivesite[36].RRspectraofCYP2D6in
the presence of DX, a substrate of this enzyme, showed the
appearanceofmarker bandsforaﬁve-coordinated high-spin
(5cHS) heme besides the 6cLS heme already present in the
resting state [33]. In agreement with those RR data, SERRS
spectra of CYP2D6 adsorbed on coated electrodes, upon
ﬂowing a DX solution into the cell (Fig. 2, spectra b),
exhibitdistinctdifferencesfromthespectraoftheenzymein
therestingstate,showingadditionalbandscharacteristicofa
5cHS heme (m3 at 1,486 cm
–1 and m2 at 1,567 cm
–1; Fig. 2,
spectra b, Table 1).
This partial transition from 6cLS to 5cHS is explained
by the displacement of a water molecule as the heme’s
distal axial ligand by DX, which is accommodated in the
active site on the distal side above the porphyrin macro-
cycle [33]. Water molecules, which may still be present in
the active site, can then rebind to the heme iron, yielding an
equilibrium between the 5cHS and 6cLS states [33, 37, 39].
The spectral changes taking place owing to the pres-
ence of DX therefore clearly indicate that the adsorbed
enzyme retains its ability to accommodate a substrate into
its active site, conﬁrming similar results reported for
CYP2D6 adsorbed on coated Ag nanoparticles [34].
Unfortunately, neither RR nor nanoparticle-based SERRS
allowed the investigation of the reversibility of the sub-
strate-binding process, since it is extremely difﬁcult to
rapidly eliminate the substrate from the enzyme-contain-
ing sample. Such problems are not encountered in the
Table 1 Vibrational frequencies (cm
–1) and relative intensities of most relevant oxidation- (m4) and spin/coordination- (m3, m2) marker bands in
SERR spectra of CYP2D6 adsorbed on MUA-coated electrodes, under different experimental conditions
Mode Fe
3+ Fe
2+
6cLS 6cLS/5cHS
Without substrate/inhibitor With inhibitor (imidazole) With substrate (dextromethorphan) 5cHS
a
m2 1,582 (0.19) 1,582 (0.14) 1,582 (0.20)/1,567 (NA)
b 1,561 (0.91)
m3 1,501 (0.08) 1,501 (0.10) 1,501 (0.09)/1,486 (0.05) 1,466 (0.65)
m4 1,371 (1.00) 1,371 (1.00) 1,371 (1.00) 1,344
c (1.00)
Relative intensities are reported after the corresponding frequencies between parentheses; values are relative to the band with an intensity of 1.00
6cLS six-coordinated low spin, 5cHS ﬁve-coordinated high spin, NA not available
a Reduced state is achieved by adding dithionite in presence of substrate
b Band not sufﬁciently resolved, frequency estimated by spectral difference [33]
c Together with this band, in spectra of CYP2D6 another one is observed at 1,360 cm
–1, characteristic of reduced inactive cytochrome P420
species
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Fig. 3 Comparison between SERRS (a, b) and resonance Raman (a0,
b0) spectra of reduced (a, a0) and oxidized (b, b0) CYP2D6. SERRS
spectra were obtained from MUA-coated Ag electrodes in the
presence of buffer alone (b) and a dithionite and DX solution in
phosphate buffer (a), while resonance Raman spectra were obtained
from CYP2D6 in solution under the same conditions. Marker bands
for oxidation (m4) and spin (m3, m2) states are indicated. Experimental
details are given in ‘‘Materials and methods’’
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123present spectroelectrochemical cell setup. The substrate is
easily removed from the enzyme-coated electrode surface
by ﬂowing buffer through the cell, reestablishing the
resting state conditions. Once the buffer had completely
replaced the DX solution in the cell, 5cHS marker bands
disappeared from SERRS spectra of CYP2D6, which
recover the shape characteristic of the 6cLS heme in the
resting state (Fig. 2, spectrum c). The exchange between
the two solutions can be operated many times, showing
every time the concomitant spectral changes, and indi-
cating an intrinsic stability of the CYP2D6–SAM–
electrode system. The similarity between the SERRS
spectra of the same enzyme sample before the introduction
of DX (Fig. 2, spectra a) and after its removal (Fig. 2,
spectrum c) clearly demonstrates that the adsorbed
CYP2D6 is able to reversibly bind a substrate, implying
that the interaction with the coated electrode surface does
not obstruct the substrate access routes to the enzyme
active site.
Reversible binding of imidazole as an exogenous
heme axial ligand
Imidazole and several imidazole derivatives are believed to
form a relatively strong bond via their nitrogen with the
heme iron of ferric CYPs, replacing the water molecule as
a distal axial ligand, and thereby preventing the binding of
oxygen to the heme in a subsequent step of the catalytic
cycle [37, 40–43]. Since oxygen binding is essential for
monooxygenase activity, often these compounds are
effective inhibitors of CYPs [44].
The SERRS spectra of CYP2D6 collected upon ﬂowing
an imidazole solution over the enzyme-coated electrode are
shown in Fig. 2, spectra d, displaying marker bands char-
acteristic of a 6cLS state (Table 1), as expected from a
CYP heme having an imidazole as the sixth axial ligand.
Although the frequencies of the imidazole complex are
identical to those reported for the resting state, the relative
intensity ratio between the m3 and m2 bands is visibly
increased with respect to the 6cLS resting state from 0.4 to
0.7 (Fig. 2spectra a and d, Table 1), in agreement with RR
data of CYP2D6 in solution (see supplementary material)
and with RR spectra previously reported for other CYP–
imidazole complexes [41, 45–47]. This difference in rela-
tive intensities has been observed in all the RR spectra of
CYP–imidazole complexes reported so far, and is generally
regarded as the characteristic spectral feature which allows
one to discriminate between the two 6cLS states having
either imidazole or water as the heme axial ligand in CYPs.
The explanation given for these characteristic relative
intensity changes observed in the presence of imidazole in
RR spectra of CYPs invokes the different resonance
conditions due to redshift of the Soret absorption induced
by imidazole in CYPs [37].
Anadditional butlesspronounced featureobservedinthe
SERRS spectrum of the CYP2D6–imidazole complex is the
intensity decrease in the region around 1,630 cm
–1, where
three overlapping bands are expected: two stretching modes
ofthe hemevinylsubstituentsaround1,620and1,630 cm
–1,
and the m10 porphyrin mode around 1,635 cm
–1 [37]. The
presence of another vinyl stretching band, otherwise invis-
iblebecauseofitsoverlapwiththemoreintenseneighboring
bands, can be substantiated by ﬁtting the data with
Lorentzian functions. A qualitative analysis of the ﬁtting
supports the hypothesis of a decrease in relative intensity of
a vinyl band around 1,630 cm
–1 for the imidazole complex
(see supplementary material), suggesting a possible pertur-
bation of the vinyls upon imidazole binding [48].
The observed change in relative intensity could be due
to a variation in the rotational conformation of the vinyls
[48]. Such variation might also cause a shift in the
stretching frequencies of the vinyls [49, 50], although in
SERRS spectra of CYP2D6 no signiﬁcant shifts are
detected. On the other hand, similar changes in relative
intensities in the 1,610–1,640-cm
–1 spectral region have
been previously reported for the imidazole complexes of
bacterial and microsomal CYPs [41, 45–47]. The fact that
imidazole binding induces similar changes in vinyl rota-
tional conformation in enzymes having rather different
active-site structures is somewhat surprising. Since vinyl
stretching modes in SERRS spectra are thought to be
enhanced via an electronic coupling with the porphyrin
[37], an alternative explanation of the changes detected
upon imidazole binding could be the difference in reso-
nance conditions due to the shift of the Soret band,
similarly to what has been proposed for the m3/m2 intensity
ratio. However, in absence of further experimental data
from other techniques, the SERRS spectra presented cannot
reliably give more detailed structural information about
conformational changes of vinyls occurring upon imidaz-
ole binding.
Similarly to what was observed for DX binding, SERRS
spectra obtained by ﬂowing buffer through the cell in place
of the imidazole solution (Fig. 2, spectrum e) have the
m3/m2 relative intensity ratio restored to 0.4, and are iden-
tical to the spectra of the enzyme in the resting state
(Fig. 2, spectra a), including the relative intensity pattern
around 1,630 cm
–1. Therefore, despite the imidazole being
expected to form a relatively strong bond with the heme
iron, the nonequilibrium situation due to the constant ﬂow
of buffer over the CYP–imidazole complex eventually
causes the complete dissociation of the imidazole from the
enzyme and the concomitant restoration of a water mole-
cule as sixth ligand, demonstrating that the CYP–imidazole
complex formation is reversible.
J Biol Inorg Chem (2008) 13:85–96 91
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The catalytic activity of CYP2D6 relies on its ability to
receive electrons from NADPH-dependent CYP reductase
to drive the catalysis and to activate molecular oxygen to
oxidize the substrate [36]. In particular, the ﬁrst of the two
electrons transferred during a catalytic cycle reduces the
iron from Fe
3+ to Fe
2+, facilitating oxygen binding to the
ferrous heme. In their resting state, CYPs usually have a
formal reduction potential (E 0) lower than that of their
electron-donor protein, so heme reduction does not occur
[36]. However, the E 0 of some CYPs, including CYP2D6,
is shifted to more positive values by the presence of a
substrate in the active site, facilitating the reduction of the
enzyme heme by the redox partner [1, 36, 51]. Therefore,
the electron transfer reaction is believed to be triggered by
substrate binding and is usually considered the third step of
the catalytic cycle [36].
In absence of reductase, immobilized CYP2D6 might
receive electrons from a reducing agent present in solution
or directly from the electrode, by applying a proper voltage.
The electron transfer process from the alternative electron
source to the enzyme can be monitored by examining the
relative presence of reduced heme species in SERRS
spectra, using solutions previously deoxygenated with
argon. This requirement is crucial since dioxygen rapidly
binds to the ferrous heme to form a complex, which upon
reaction with another electron quickly turns into an instable
peroxo-ferric intermediate, continuing the catalytic cycle
and hampering the observation of reduced species [36].
Upon ﬂowing over the adsorbed enzyme a deoxygenated
and buffered DX solution containing sodium dithionite as a
reducing agent, the SERRS spectrum shown in Fig. 2,
spectrum f is observed. It mainly presents bands with fre-
quencies characteristic of a reduced 5cHS heme (Table 1),
which are markedly different from all the spectra of oxi-
dized CYP2D6 obtained so far (Fig. 2, spectra a–e). A
noticeable feature is the coexistence of two m4 oxidation
marker bands at 1,344 and 1,360 cm
–1, originating from
the downshift and the splitting of the corresponding m4 band
observed at 1,371 cm
–1 in the oxidized enzyme, and indi-
cating the presence of two different heme species. While
the m4 band at 1,344 cm
–1—consistent with the other bands
observed—is typical of a ferrous CYP in its active form,
the band at 1,360 cm
–1 is characteristic of a ferrous inac-
tive form called P420 [20, 37, 52, 53]. This strongly
suggests that upon reduction a signiﬁcant fraction of the
immobilized enzyme undergoes structural changes leading
to its inactivation. However, according to the RR spectra of
the ferrous active and inactive forms previously reported
for other CYPs, the active enzyme still contributes to a
signiﬁcant extent to the observed CYP2D6 SERRS spec-
trum, whereas no marker bands for the inactive species
other than the one at 1,360 cm
–1 can be detected. In fact, in
all the RR or SERRS spectra of P420 species reported so
far for various CYPs, the m4 band is the strongest, with
relative intensity much higher than for the other bands,
whereas in spectra of active enzymes the intensity pattern
is different, with many other bands having intensities
comparable to that of the m4 band [20, 37, 52–55]. In the
spectra of reduced CYP2D6, the bands in the 1,400–1,650-
cm
–1 region have relative intensities comparable to that of
the m4 band of the active enzyme (at 1,344 cm
–1), whereas
the bands of the P420 species are likely to have relative
intensities much smaller than that of the P420 m4 band at
1,360 cm
–1, and are therefore buried under the more
intense bands due to the active enzyme.
Notably, this partial inactivation is not due to the
immobilization as such, since every attempt to obtain
reduced free CYP2D6 in solution by dithionite addition led
to samples containing inactive enzyme besides the active
one, yielding RR spectra which closely resemble the
SERRS spectrum of the adsorbed enzyme (Fig. 4, spec-
tra a). The inactivation might be due to laser-induced
photodegradation, since laser illumination is common to
both RR and SERRS. However, the use of laser powers
lower than 5 mW yielded identical spectra (data not
shown), and small amounts of inactive enzyme were pre-
viously detected in dithionite-reduced CYP2D6 samples
using nonlaser techniques as well, such as UV–vis elec-
tronic absorption spectroscopy [38].
When reduction of CYP2D6 with dithionite is attempted
in the absence of a substrate, the resulting SERRS spectrum
presents some differences with respect to that of the sub-
strate-bound enzyme (Fig. 4). In particular, the presence of
DX in the dithionite solution increases the amount of
reduced active enzyme at the expense of the oxidized and
reduced inactive forms, as deduced from the increase in
intensity of the band at 1,344 cm
–1 and the concomitant
decrease of the bands at 1,360 and 1,371 cm
–1. Thus, the
presence of DX in the heme pocket appears to affect the
redox activity of the enzyme, possibly by causing a shift of
its E 0 to more positive values, as previously observed for
CYP2D6 on a polyaniline-doped glassy carbon electrode in
the presence of ﬂuoxetine [51].
On the other hand, in the electrochemical approach the
control of the CYP2D6 oxidation state is attempted by
applying a constant potential to the Ag working electrode,
during which a SERRS spectrum is recorded to monitor the
relative abundance of oxidized and reduced species char-
acteristic for that voltage. Complete oxidation or reduction
of the protein should in principle be obtained by applying a
potential which is sufﬁciently more positive or more neg-
ative with respect to its E 0, respectively.
Besides the advantage of controlling the enzyme oxi-
dation state and therefore, under adequate conditions, of
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123supplying the electrons and driving the catalytic reaction,
an additional beneﬁt of this approach is the possibility to
study the electron transfer process quantitatively. In sta-
tionary SERRS spectroelectrochemistry the analysis of a
set of spectra acquired at various potentials can assess the
Nernstian character the electron transfer process, yielding
its E 0 value [5, 14, 19]. Moreover, a time-resolved
approach based on potential-jump experiments can give
information about the electron transfer kinetic parameters
[5, 56].
However, despite the broad potential window investi-
gated (from +0.15 V to –1.0 V) the electrochemical
approach appeared to be unsuccessful in reducing the
immobilized CYP2D6 completely, and failed to generate
any reduced active enzyme at all. In fact, although there is
some variability in the spectral data obtained from distinct
electrodes, a common feature is the persistence of an
intense marker band for the oxidized enzyme at 1,371 cm
–1
even at potentials as negative as –1.0 V, together with the
appearance of the marker band for a reduced inactive
enzyme at 1,360 cm
–1 (Fig. 5). An additional feature in the
SERRS spectra of reduced CYP2D6 is the lack of any
inﬂuence of DX (see supplementary material), contrary to
what is observed with chemical reduction.
Although the E 0 of CYP2D6 on MUA-coated Ag
electrodes might differ signiﬁcantly from the E 0 reported
for a polyaniline-doped glassy carbon electrode (–0.12 V)
[1, 51], the persistence of a consistent amount of oxidized
enzyme at –1.0 V suggests an incomplete electron transfer.
Despite the large variability of the E 0 values found in the
literature, depending on the CYP and on the method
employed, no E 0 is reported below –0.6 V [1]. Consistent
with this fact, CYP2D6 is effectively and completely
reduced by a 5 mg mL
–1 dithionite solution having a cal-
culated redox potential of approximately –0.7 V [57].
Therefore, on a pure thermodynamical basis, the applica-
tion of a potential more negative than –0.7 V to the Ag
electrode should lead to a reduction of the adsorbed
enzyme. The marked difference in the amount of reduced
species obtained with chemical and electrochemical
reduction (Fig. 6) might therefore be due to slower kinetics
of the electron transfer process when using the second
method.
The efﬁciency of the electrochemical reduction via the
electrode is likely to be dependent on both the distance and
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123the orientation of the adsorbed protein with respect to the
electrode surface [1, 3], whereas these two factors probably
do not inﬂuence the dithionite reduction process. In vivo,
electron transfer between the electroactive heme center,
deeply buried inside the protein structure, and the electron-
donating reductase occurs via an interaction involving
speciﬁc domains on the protein surfaces [1, 3], with a
strictly deﬁned orientation. Conversely, the electron
transfer from dithionite in solution will not be sensitive to
the protein orientation, considering the capacity of the
reducing agent to approach the enzyme from more direc-
tions. Moreover, while the minimum distance between the
enzyme active site and the electrode surface is equivalent
to the thickness of the MUA coating (approximately 19 A ˚
[22]) plus the heme–protein surface distance, dithionite is
free to diffuse closer to the enzyme redox center. There-
fore, an unfavorable enzyme orientation with respect to the
coated metal surface or a too large heme–electrode distance
would be consistent with experimental data, since it would
slow down or suppress the electron transfer from the
electrode, while dithionite would still be able to effectively
reduce the CYP2D6 heme. Moreover, the inability of the
electrochemical approach to generate any amount of
reduced enzyme in its active form, which is otherwise
observed in dithionite-reduced protein samples, suggests
that CYP2D6 inactivation is triggered by the application of
potentials between –0.4 and –1.0 V during the enzyme-
reduction attempts.
The intense electric ﬁeld present at the interface of the
SAM-coated Ag electrodes, which has recently been indi-
cated as the main reason for the extensive conversion of the
immobilized bacterial CYP101 to its inactive P420 forms
[20], might be the cause of this potential-induced inacti-
vation. However, according to the theory originally
proposed by Smith and White [58] and later adapted by
Murgida and Hildebrandt [22] and Lecomte et al. [59]t o
explain the behavior of c-type cytochromes adsorbed on
electrodes, the intensity of this interfacial electric ﬁeld is
expected to decrease as the applied potential approaches
the potential of zero charge (–0.97 V for a polycrystalline
Ag electrode) [13, 60–62]. Therefore, supposing that this
theoretical model could be extended to CYPs (as it has
been assumed in the case of CYP101 [20]), the interfacial
electric ﬁeld should be more intense at –0.1 V than at –
1.0 V, whereas CYP2D6 inactivation occurs at more neg-
ative potentials, suggesting that in this case the interfacial
electric ﬁeld intensity as such is not responsible for the
enzyme conversion to the P420 form upon electrochemical
reduction. This hypothesis would be compatible with the
electric-ﬁeld-induced inactivation reported for CYP101
upon immobilization [20], considering that CYP101 is a
soluble cytosolic enzyme, while CYP2D6 is a peripheral
membrane protein, and the same interfacial electric ﬁeld
might have a very different effect on their respective
active-site structures.
Besides tentatively excluding the interfacial electric
ﬁeld intensity as a cause, SERRS data alone cannot support
any explanation for the CYP2D6 potential-induced inacti-
vation. Additional detailed structural data on the secondary
and tertiary structures of the adsorbed protein and on the
nature and position of the amino acid residues interacting
with the MUA monolayer would be highly valuable, and
they might be retrieved in further studies using SERRS in
combination with surface-enhanced infrared absorption
spectroscopy [63] as well as other techniques [64–66].
Conclusions
Upon immobilization on MUA-coated Ag electrodes, the
human enzyme CYP2D6 retains its active-site structure, its
ability to reversibly bind a substrate (DX) and an exoge-
nous heme ligand (imidazole), and its capacity to exchange
electrons, demonstrating the efﬁciency of the coating to
prevent major protein conformational changes or denatur-
ation. However, despite its success in preserving an intact
protein structure, the MUA coating appears to be unsuit-
able for performing direct electrochemistry experiments on
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123immobilized CYP2D6, since its reduced state could not be
adequately achieved by varying the electrode potential.
The application of potentials from –0.4 to –1.0 V appears
to induce enzyme inactivation instead. Among other factors
inﬂuencing the redox activity, a more favorable enzyme
orientation or distance with respect to the electrode surface
might be achieved using other coatings, an approach cur-
rently under study in our group.
In general, SERRS spectroscopy on coated Ag surfaces
was proven to be successful in monitoring the active-site
structure of immobilized CYP2D6, enabling the detection
of reversible substrate and ligand binding using only very
low amounts of protein. Besides its technological relevance
as an optical biosensing tool, this technique might have a
signiﬁcant potential for fundamental research on the
mechanisms of catalysis for CYPs, as well as for other
heme enzymes.
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